Medical aspects of drug use in the gym

Drug and Therapeutics Bulletin

Volumn 42, Issue 1, 2004, Pages 1-5

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

AMPHETAMINE DERIVATIVE; ANABOLIC AGENT; ANTIESTROGEN; CENTRAL STIMULANT AGENT; CHORIONIC GONADOTROPIN; CLENBUTEROL; COCAINE; EPHEDRINE; ESTROGEN; GROWTH HORMONE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; IRON; LOW DENSITY LIPOPROTEIN CHOLESTEROL; METANDIENONE; METHYLTESTOSTERONE; NALBUPHINE; NON PRESCRIPTION DRUG; PLACEBO; RECOMBINANT ERYTHROPOIETIN; RECOMBINANT GROWTH HORMONE; STANOZOLOL; TAMOXIFEN; TESTOSTERONE;

ACCIDENT; ACIDEMIA; ACNE; ACNE CYSTICA; ACROMEGALY; AGGRESSION; AGITATION; ANOREXIA; ANXIETY; ARTHRALGIA; ARTICLE; ATHLETE; BEHAVIOR DISORDER; BODY BUILDING; BODY WEIGHT DISORDER; BRAIN DISEASE; BREAST ATROPHY; CARDIOVASCULAR DISEASE; CARPAL TUNNEL SYNDROME; CLINICAL PRACTICE; CLINICAL TRIAL; COLORECTAL CANCER; CREUTZFELDT JAKOB DISEASE; DELIRIUM; DEPRESSION; DIABETES MELLITUS; DIET SUPPLEMENTATION; DISEASE EXACERBATION; DIZZINESS; DOSE RESPONSE; DRUG ABUSE; DRUG FATALITY; DRUG METABOLISM; ENDOCRINE DISEASE; ESTHETICS; FATIGUE; FETUS DISEASE; FLUID RETENTION; GROWTH DISORDER; GYNECOLOGIC DISEASE; GYNECOMASTIA; HEADACHE; HEART ARRHYTHMIA; HEART FAILURE; HEART INFARCTION; HEART MUSCLE FIBROSIS; HEART PALPITATION; HEART VENTRICLE HYPERTROPHY; HEAT STRESS; HIRSUTISM; HOMICIDE; HOSTILITY; HUMAN; HYPERTENSION; HYPOGLYCEMIA; HYPOMANIA; INSOMNIA; IRON OVERLOAD; IRRITABILITY; LARYNX DISORDER; LEARNING; LIBIDO DISORDER; LIVER CIRRHOSIS; LIVER DYSFUNCTION; LIVER TOXICITY; LIVER TUMOR; MALE INFERTILITY; MALE TYPE ALOPECIA; MANIA; MENSTRUATION DISORDER; MENTAL DISEASE; METABOLIC DISORDER; MOOD DISORDER; MUSCLE WEAKNESS; OBSTRUCTIVE JAUNDICE; OSTEOARTHRITIS; PELIOSIS HEPATIS; PERFORMANCE; PHYSICAL CAPACITY; POPULATION RESEARCH; PROSTATE CANCER; PROSTATE HYPERTROPHY; PSYCHOSIS; SEIZURE; SKIN DISEASE; SPORT; STROKE; SUDDEN DEATH; SUICIDE; TACHYCARDIA; TESTIS ATROPHY; THROMBOSIS; TREMOR; UNITED KINGDOM; URINARY TRACT DISEASE; VIOLENCE; VIRILIZATION; WITHDRAWAL SYNDROME;

EID: 0345874618     PISSN: 00126543     EISSN: None     Source Type: Journal    
DOI: 10.1136/dtb.2004.4211     Document Type: Article

References (35)

1. Lenehan P et al. A study of anabolic steroid use in the North West of England. J Performance Enhancing Drugs 1996; 1: 57-70.
2. Korkia P Stimson GV. Indications of prevalence, practice and effects of anabolic steroid use in Great Britain. Int J Sports Med 1997; 18: 557-62.
3. Dawson RT. Drugs in sport - the role of the physician. J Endocrinol 2001; 170: 55-61.
4. Korkia, Stimson GV. Anabolic steroid use in Great Britain. An exploratory investigation. London: The Centre for Research on Drugs and Health Behaviour, 1993.
5. Kicman AT, Gower DB. Anabolic steroids in sport: biochemical, clinical and analytical perspectives. Ann Clin Biochem 2003; 40: 321-56.
6. Bhasin S et al. The effects of supraphysiological doses of testosterone on muscle size and strength in normal men. N Engl J Med 1996; 335: 1-7.
7. Evans NA. Gym and tonic: a profile of 100 male steroid users. Br J Sports Med 1997; 31: 54-8.
8. Soe KL et al. Liver pathology associated with the use of anabolic-androgenic steroids. Liver 1992; 12: 73-9.
9. Wemyss-Holden SA et al. Steroid abuse in athletes, prostatic enlargement and bladder outflow obstruction - is there a relationship? B J Urol 1994; 74: 476-8.
10. Cohen JC et al. Altered serum lipoprotein profiles in male and female power lifters ingesting anabolic steroids. Physician Sports Med 1986; 14: 131-6.
11. Pärssinen M, Seppälä T. Steroid use and long-term health risk in former athletes. Sports Med 2002; 32: 83-94.
12. Ferenchick GS et al. Anabolic-androgenic steroid abuse in weight litters: evidence for the activation of the hemostatic system Am J Hematol 1995; 49: 282-8.
13. Anderson RA et al. Haemostatic effects of supraphysiological levels of testosterone in normal men. Thromb Haemost 1995; 74: 693-7.
14. Nieminen MS et al. Serious cardiovascular side effects of large doses of anabolic steroids in weight lifters. Eur Heart J 1996; 17: 1576-83.
15. Madea B et al. Medico-legal aspects of doping. J Clin Forensic Med 1998; 5: 1-7.
16. Pope HG, Katz DL. Psychiatric and medical effects of anabolic-androgenic steroid use. A controlled study of 160 athletes. Arch Gen Psychiatry 1994; 51: 375-82.
17. Choi PY et al. High-dose anabolic steroids in strength athletes: effects upon hostility and aggression. Hum Psychopharmacol 1990; 5: 349-56.
18. Korkia P. Anabolic-androgenic steroids series: part II. Psychological effects of anabolic steroid use: a review. J Subst Misuse 1998; 3: 106-13.
19. Thiblin I et al. Cause and manner of death among users of anabolic androgenic steroids J Forensic Sci 2000; 45: 16-23.
20. Su T-P et al. Neuropsychiatric effects of anabolic steroids in male normal volunteers. JAMA 1993; 269: 2760-4.
21. Pope HG et al. Effects of supraphysiological doses of testosterone on mood and aggression in normal men. Arch Gen Psychiatry 2000; 57: 133-40.
22. Tricker R et al. The effects of supraphysiological doses of testosterone on angry behavior in healthy eugonadal men - a clinical research center study. J Clin Endocrinol Metab 1996; 81: 3754-8.
23. Sonksen PH. Hormones and sport. Insulin, growth hormone and sport. J Endocrinol 2001; 170: 13-25.
24. Jenkins PJ. Growth hormone and exercise. Clin Endocrinol 1999; 50: 683-9.
25. Yarasheski KE et al. Effect of growth hormone and resistance exercise on muscle growth in young men. Am J Physiol 1992; 262: E261-7.
26. Deyssig R et al. Effect of growth hormone treatment on hormonal parameters, body composition and strength in athletes. Acta Endocrinol 1993; 128: 313-8.
27. Rennie MJ. Claim for the anabolic effects of growth hormone: a case of the Emperor's new clothes? Br J Sports Med 2003; 37: 100-5.
28. Dawson RT, Harrison MW. Use of insulin as an anabolic agent. Br J Sports Med 1997; 31: 259.
29. Scott WC. The abuse of erythropoietin to enhance athletic performance. JAMA 1990; 264: 1660.
30. Armstrong DJ, Reilly T. Blood boosting and sport. In: Mottram DR (Ed). Drugs in sport. Third edition. London and New York: Routledge, 2003.
31. George AJ. Central nervous system stimulants. In: Mottram DR (Ed). Drugs in sport. Third edition. London and New York: Routledge, 2003.
32. Wines Jr JD et al. Nalbuphine hydrochloride dependence in anabolic steroid users. Amer J Addict 1999; 8: 161-4.
33. Armstrong DJ, Chester N. IOC regulations in relation to drugs used in the treatment of respiratory tract disorders. In: Mottram DR (Ed). Drugs in sport. Third edition. London and New York: Routledge, 2003.
34. Geyer H et al. High doses of the anabolic steroid metandienone found in dietary supplements. Eur J Sport Sci 2003; 3: 1-5.
35. British Medical Association. The role and responsibilities of doctors in doping in sport. In: Drugs in sport: the pressure to perform. London: BMJ Books, 2002.